(VCBeat) May. 10, 2021 -- Access Medical Systems (AMS), the parent company of ET Healthcare, has announced the closing of a new round of funding of more than $100 million. This round of financing was jointly led by Sequoia Capital China and GL Ventures, with participation from Kaiser Permanente, Sinovation Ventures, WisdoMont Asset Management, Hidragon Capital and existing investors including Qiming Venture Partners, Matrix Partners China and Legend Capital. Gelu Capital acted as the exclusive financial adviser. The funds raised will be used to develop new technologies and products, expand global markets and improve production capacity.
Access Medical Systems was founded in 2004, with a vision of providing high-quality medical devices in the field of Critical care, Obstetrics & Gynaecology and highly focused on Cardiology, Diabetology & Vascular Diagnostic devices which are designed to meet the individual and collective needs of our patrons.
Since the company was founded, We are continuously serving our customers by offering world-class healthcare products. Our product range includes Doppler's from Arjo Huntleigh and we also deal with MNC's like Acelity, DyAnsys, etc.
AMS has two sub-brands, ET Healthcare and Gator Bio, in the field of in-vitro diagnostics and life sciences. With its innovative biosensor technology and detection platform, the company aims to become a new leader in the global market.
The core competitiveness of AMS is derived from its Test-on-A-Probe (TOP), A biosensor with more than 50 patents worldwide. The TOP technique loads different detection techniques on a single probe to complete the analysis of proteins, antibodies, nucleic acids, small molecules and cells. So far, the company has successfully developed fluorescence detection, chemiluminescence detection, no label detection and other technology platforms based on the probe. Its original technology, industrialization capacity and market potential have been fully proven in a number of market segments.
Sequoia Capital China, as the "entrepreneur behind entrepreneur", focuses on investment in four directions including technology/media, healthcare, consumer goods/modern services and industrial technology. Over the past 15 years, Sequoia Capital China has invested in nearly 600 enterprises with distinctive technical characteristics, innovative business models, and high growth and development potential.
GL Ventures was set up by private equity heavyweight Hillhouse Capital to invest in emerging startups in February 2020. GL Ventures focuses on four areas: biomedicine and medical devices, software services and initiatives in tech innovations, consumer internet and technology, and emerging consumer brands and services.